{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:15:55Z","timestamp":1783188955823,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017954","name":"Fujian Provincial Finance Department","doi-asserted-by":"publisher","award":["2024CZ017"],"award-info":[{"award-number":["2024CZ017"]}],"id":[{"id":"10.13039\/100017954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750"],"award-info":[{"award-number":["320.6750"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["2024-13-28"],"award-info":[{"award-number":["2024-13-28"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Informatics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijmedinf.2026.106542","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:08:23Z","timestamp":1781107703000},"page":"106542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predicting recurrence within 5 years in Early-Stage lung adenocarcinoma with micropapillary and solid patterns"],"prefix":"10.1016","volume":"218","author":[{"given":"Zhongjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengzhe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106542_b0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106542_b0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International association for the study of lung cancer\/american thoracic society\/european respiratory society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106542_b0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2023.01.002","article-title":"Micropapillary and Solid Histologic patterns in N1 and N2 Lymph Node Metastases are Independent Factors of Poor Prognosis in patients with Stages II to III Lung Adenocarcinoma","volume":"18","author":"Li","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"13","key":"10.1016\/j.ijmedinf.2026.106542_b0020","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1200\/JCO.2011.37.2185","article-title":"The novel histologic International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival","volume":"30","author":"Warth","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.ijmedinf.2026.106542_b0025","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2015.60.9818","article-title":"Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival","volume":"33","author":"Ujiie","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106542_b0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/2159-8290.CD-22-0373","article-title":"Artificial Intelligence and Machine Learning Technologies in Cancer Care: addressing Disparities, Bias, and Data Diversity","volume":"12","author":"Dankwa-Mullan","year":"2022","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106542_b0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trecan.2019.02.002","article-title":"Rise of the Machines: advances in Deep Learning for Cancer Diagnosis","volume":"5","author":"Levine","year":"2019","journal-title":"Trends Cancer."},{"issue":"8","key":"10.1016\/j.ijmedinf.2026.106542_b0040","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","article-title":"From patterns to patients: advances in clinical machine learning for cancer diagnosis, prognosis, and treatment","volume":"186","author":"Swanson","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijmedinf.2026.106542_b0045","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1245\/s10434-025-18946-7","article-title":"Computed Tomography-Pathology Deep Learning Model for the Precise Prediction of Recurrence in Pathological Stage IA Lung Adenocarcinoma","volume":"33","author":"Zhang","year":"2026","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0050","article-title":"Development and validation of an LDCT-based deep learning radiomics nomogram for predicting postoperative recurrence of stage Ia lung adenocarcinoma","volume":"15","author":"Lan","year":"2025","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ijmedinf.2026.106542_b0055","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70291","article-title":"Radiological, molecular, and pathological factors unite: a model for predicting recurrence-free survival in pathological stage I lung adenocarcinoma","volume":"17","author":"Zeng","year":"2026","journal-title":"Thorac Cancer."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106542_b0060","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1245\/s10434-025-18807-3","article-title":"Explainable PET-Based Habitat Modeling for predicting Postoperative Recurrence Risk in Invasive Lung Adenocarcinoma","volume":"33","author":"Zheng","year":"2026","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106542_b0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.62347\/XOFY6189","article-title":"Analysis of influencing factors of recurrence after thoracoscopic resection in patients with stage I a lung adenocarcinoma","volume":"16","author":"Wei","year":"2026","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0070","doi-asserted-by":"crossref","unstructured":"Liu J, Ju S, Zheng Z, et al. Construction of novel radiomics nomogram model based on preoperative CT to predict lymphovascular tumor embolus and recurrence-free survival in early T1-2a stage lung adenocarcinomas. BMC Med Imaging. Feb 23 2026;26(1).","DOI":"10.1186\/s12880-026-02240-3"},{"key":"10.1016\/j.ijmedinf.2026.106542_b0075","doi-asserted-by":"crossref","unstructured":"Liao R, Zhang Y, Li G. Construction and validation of a recurrence prediction model for lung adenocarcinoma after treatment integrating radiomics features and clinical indicators. BMC Cancer. Dec 10 2025;26(1):103.","DOI":"10.1186\/s12885-025-15427-8"},{"key":"10.1016\/j.ijmedinf.2026.106542_b0080","doi-asserted-by":"crossref","unstructured":"Li Y, Xu R, Xian J, Wang Z, Chen W, Li W. Development and validation of a predictive model for recurrence in postoperative patients with stage \u2160A1-\u2162A non-small cell lung cancer. BMC Cancer. Nov 27 2025;26(1):29.","DOI":"10.1186\/s12885-025-15275-6"},{"issue":"12","key":"10.1016\/j.ijmedinf.2026.106542_b0085","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/RLU.0000000000006086","article-title":"MetaPredictomics: a Comprehensive Approach to Predict Postsurgical Non-Small Cell Lung Cancer Recurrence using Clinicopathologic, Radiomics, and Organomics Data","volume":"50","author":"Amini","year":"2025","journal-title":"Clin. Nucl. Med."},{"issue":"10","key":"10.1016\/j.ijmedinf.2026.106542_b0090","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.jtho.2020.06.001","article-title":"A Grading System for Invasive Pulmonary Adenocarcinoma: a Proposal from the International Association for the Study of Lung Cancer Pathology Committee","volume":"15","author":"Moreira","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"10335","key":"10.1016\/j.ijmedinf.2026.106542_b0095","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106542_b0100","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S2213-2600(23)00041-3","article-title":"Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial","volume":"11","author":"Aokage","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.ijmedinf.2026.106542_b0105","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ejso.2019.01.220","article-title":"Solid predominant subtype in lung adenocarcinoma is related to poorprognosis after surgical resection: a systematic review and meta-analysis","volume":"45","author":"Miyahara","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107445","article-title":"Micropapillary and solid components as high-grade patterns in IASLC grading system of lung adenocarcinoma: Clinical implications and management","volume":"187","author":"Mikubo","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijmedinf.2026.106542_b0115","unstructured":"Riely GJ, Wood DE, Aisner DL, et al. NCCN Guidelines\u00ae Insights: Non-Small Cell Lung Cancer, Version 7.2025. J Natl Compr Canc Netw. Sep 2025;23(9):354-362."},{"issue":"1","key":"10.1016\/j.ijmedinf.2026.106542_b0120","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233244","article-title":"Predicting recurrence after sublobar resection in patients with lung adenocarcinoma using preoperative chest CT scans","volume":"313","author":"Yun","year":"2024","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106542_b0125","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31283","article-title":"Minor (\u2264 10%) Ground-Glass Opacity Component in Clinical Stage I Non-Small Cell Lung Cancer: Associations with Pathologic Characteristics and Clinical Outcomes","volume":"223","author":"Li","year":"2024","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0130","doi-asserted-by":"crossref","unstructured":"Xu Y, Wang Z, Tao Y, et al. Ground-Glass Opacity Component as a Protective Factor for Patients With Invasive Adenocarcinoma \u22643 cm With Micropapillary or Solid Pathological Patterns. Eur J Cardiothorac Surg. Sep 2 2025;67(9).","DOI":"10.1093\/ejcts\/ezaf285"},{"issue":"9","key":"10.1016\/j.ijmedinf.2026.106542_b0135","first-page":"10562","article-title":"Prognostic significance of micropapillary and solid patterns in stage IA lung adenocarcinoma","volume":"13","author":"Peng","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106542_b0140","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s00330-022-09379-x","article-title":"Prediction of high-grade patterns of stage IA lung invasive adenocarcinoma based on high-resolution CT features: a bicentric study","volume":"33","author":"Dong","year":"2023","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ijmedinf.2026.106542_b0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejcts.2006.12.018","article-title":"Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins\u2013implications for patient selection for segmentectomy","volume":"31","author":"Sienel","year":"2007","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"6","key":"10.1016\/j.ijmedinf.2026.106542_b0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJMoa2212083","article-title":"Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer","volume":"388","author":"Altorki","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106542_b0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jtcvs.2011.10.023","article-title":"Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system","volume":"143","author":"Carr","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102664","article-title":"The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer","volume":"122","author":"Ciardiello","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0165","article-title":"Comparison of the efficacy and safety of first-line treatments for of advanced EGFR mutation-positive non-small-cell lung cancer in asian populations: a systematic review and network meta-analysis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijmedinf.2026.106542_b0170","article-title":"Real-World evidence of EGFR Targeted Therapy in NSCLC- a Brief Report of Decade Long Single Center Experience","volume":"4","author":"Chougule","year":"2023","journal-title":"JTO Clin Res Rep."},{"issue":"2","key":"10.1016\/j.ijmedinf.2026.106542_b0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/path.6416","article-title":"Multi-omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I-III micropapillary lung adenocarcinoma","volume":"266","author":"Qu","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.ijmedinf.2026.106542_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108672","article-title":"Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): a multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study)","volume":"206","author":"Fujino","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijmedinf.2026.106542_b0185","doi-asserted-by":"crossref","unstructured":"Zhao P, Zhen H, Zhao H, Zhao L, Cao B. Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials. BMC Cancer. Mar 26 2022;22(1):328.","DOI":"10.1186\/s12885-022-09444-0"},{"key":"10.1016\/j.ijmedinf.2026.106542_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107453","article-title":"Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation","volume":"188","author":"Kitagawa","year":"2024","journal-title":"Lung Cancer"}],"container-title":["International Journal of Medical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505626002820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386505626002820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:25:00Z","timestamp":1783185900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386505626002820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S1386505626002820"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106542","relation":{},"ISSN":["1386-5056"],"issn-type":[{"value":"1386-5056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting recurrence within 5 years in Early-Stage lung adenocarcinoma with micropapillary and solid patterns","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106542"}}